Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals
- 1 August 2018
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 52 (2) , 269-271
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- 1371. Safety, Tolerability, and Pharmacokinetics of Multiple Doses of TP-6076, a Novel, Fully Synthetic Tetracycline, in a Phase 1 StudyOpen Forum Infectious Diseases, 2018
- The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Expert Review of Anti-infective Therapy, 2016
- Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012Antimicrobial Agents and Chemotherapy, 2014
- Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug?Journal of Infection, 2013
- Current control and treatment of multidrug-resistant Acinetobacter baumannii infectionsThe Lancet Infectious Diseases, 2008
- Acinetobacterinfections: a growing threat for critically ill patientsEpidemiology and Infection, 2007
- Multicenter Studies of Tigecycline Disk Diffusion Susceptibility Results for Acinetobacter sppJournal of Clinical Microbiology, 2007
- Tigecycline MIC Testing by Broth Dilution Requires Use of Fresh Medium or Addition of the Biocatalytic Oxygen-Reducing Reagent Oxyrase To Standardize the Test MethodAntimicrobial Agents and Chemotherapy, 2005